首页 › 胰腺癌 › 加利福尼亚州 › San Francisco
San Francisco CA 胰腺癌临床试验
20项针对 胰腺癌的研究正在 San Francisco及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
招募中2 期
- Local Institution - 0096, San Francisco
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
招募中1/2 期
- Research Site, San Francisco
Distance-Based Exercise to Preserve Function and Prevent Disability
招募中
- Kaiser Permanente-San Francisco, San Francisco
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
招募中3 期
- University of California, San Francisco, San Francisco
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
招募中3 期
- Investigative Site US034, San Francisco
UCSF PANC Cyst Registry
招募中观察性研究
- University of California, San Francisco, San Francisco
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
招募中观察性研究
- University of California, San Francisco, San Francisco
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
招募中观察性研究
- UCSF Medical Center-Mount Zion, San Francisco
- UCSF Medical Center-Parnassus, San Francisco
- UCSF Medical Center-Mission Bay, San Francisco
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
招募中3 期
- California Pacific Medical Center-Pacific Campus, San Francisco
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
招募中1 期
- UCSF, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
招募中1/2 期
- University of California San Francisco Cancer Center, San Francisco
Pancreatic Cancer Early Detection Consortium
招募中观察性研究欢迎健康志愿者
- University of California, San Francisco (UCSF), San Francisco
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
招募中3 期
- California Pacific Medical Center-Pacific Campus, San Francisco
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
招募中
- Zuckerberg San Francisco General, San Francisco
- Kaiser Foundation Research Institute, San Francisco
- University of San Francisco, San Francisco
A Study of MGC028 in Participants With Advanced Solid Tumors
招募中1 期
- UCSF - Helen Diller Family Cancer Center, San Francisco
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II)
招募中早期 I 期
- Stanford University, San Francisco
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
招募中1/2 期
- University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
招募中1/2 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
招募中2 期
- Ohio State University-Telemedicine, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, San Francisco
其他城市的 胰腺癌试验
- Houston, TX61 项研究
- New York City, NY60 项研究
- Boston, MA43 项研究
- Nashville, TN39 项研究
- Los Angeles, CA35 项研究
- St. Louis, MO33 项研究
- Arlington, VA33 项研究
- San Antonio, TX31 项研究
- Baltimore, MD30 项研究
- Philadelphia, PA26 项研究
- Tampa, FL26 项研究
- Durham, NC24 项研究
San Francisco的其他研究
- 前列腺癌45 项研究
- 乳腺癌43 项研究
- 非小细胞肺癌36 项研究
- 癌症（所有类型）35 项研究
- 心力衰竭29 项研究
- 转移性癌症28 项研究
- 黑色素瘤22 项研究
- 肺癌22 项研究
- 卵巢癌19 项研究
- 心血管疾病18 项研究
- 结直肠癌18 项研究
- 胶质母细胞瘤17 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月7日。每项研究自行设定入选标准，由研究团队决定谁能参与。